Company Overview and News
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
BHRYY 534816 INFRATEL
Bhopal: The smart poles which the Bhopal smart city development corporation limited (BSCDCL) had started installing across the city in June 2017, are yet to start operations. As many as 98 such poles have been installed till date and more than fifty per cent of the poles are non-functional.
BHRYY 534816 INFRATEL
The broader indices are trading on a positive note this Thursday morning with the Nifty up 26 points at 10,641 and the Sensex trading higher by 88 points at 34,994.
BHRYY 500325 BHUSANSTL RELIANCE ICLQY 533155 532712 BHRQY TTNQY JUBLFOOD 533278 511288 500470 532540 RCOM 534816 RIGD JBLWY HDFCBANK GAILF INFRATEL BHARTIARTL CLNDY 500055 RLNIY GRUH KMBKY GRHFY 532822 539207 532454 TTST TATASTEEL TATLY HDB 500180 GAILY KOTAKBANK IDEA TCS 500247 COALINDIA MANPASAND
The broader indices are trading weak this Wednesday afternoon, with the Nifty down 46 points at 10,587 and the Sensex shedding 131 points at 34,818.
GRASIM BHUSANSTL DABUR TCHQY ICLQY MARKSANS 532712 532755 DBRQY 532960 JUSTDIAL 500096 PIDILITIND RCOM 534816 PDLTY 500179 BJJQY BEL CLNDY 500055 500331 BHQRY 524404 GRSJY CLGQY 532822 TECHM 500380 BAJFINANCE TATASTEEL TATLY 500300 HINDPETRO JKLAKSHMI 500104 COALINDIA 500188 HINDZINC BHRYY GODREJIND HNDZY 533155 BHRQY JUBLFOOD 533278 IDBLZ HCL-INSYS 500470 535648 CL JBLWY RADICO INFRATEL BHARTIARTL TWL 500034 HINDALCO IBVENTURES IBN 532966 532454 HNDNF GRSXY 532497 ICICIBANK TTST 532174 IDEA 500049 500164 JSTQY 500440
The broader are trading flat this Wednesday morning, with the Nifty down 48 points at 10,584 and the Sensex shedding 130 points at 34,818.
BHUSANSTL DABUR ICLQY 532712 DBRQY 532960 JUSTDIAL 500096 PIDILITIND RCOM 534816 PDLTY 500179 TORNTPOWER BEL CLNDY 500055 500331 BHQRY 532822 500380 TCS HINDPETRO JKLAKSHMI 500104 COALINDIA BHRYY 512573 532779 533155 BHRQY TTNQY JUBLFOOD 533278 IDBLZ HCL-INSYS 532540 535648 JBLWY RADICO INFRATEL BHARTIARTL TWL HINDALCO AVANTI IBVENTURES IBN 532966 532454 HNDNF 532497 ICICIBANK 532174 IDEA 500049 JSTQY 500440
The broader are trading flat this Tuesday morning, with the Nifty flat at 10,688 and the Sensex shedding 13 points at 35,152.
500408 533096 HCTHY TCHQY ICLQY 532712 532755 532960 JUSTDIAL PIDILITIND RCOM 534816 PDLTY 532281 GAILF 500570 ASHOKLEY 500331 SBAZ EDELWEISS TVSMOTOR 524804 532822 MRZUY AKLD 532500 TECHM MARUTI HCLTECH GAILY 500103 AKLS WABAG ANDHRABANK HINDCOPPER BHRYY AUROPHARMA 532418 IDBLZ 532343 535648 532461 RADICO INFRATEL 500477 TATAMOTORS UBNC IBVENTURES 513599 532922 VTUWY BHEL 533269 532497 PNJZY ARBQY IDEA TATAELXSI BRHTY PNB ADANIPOWER JSTQY TTM
Benchmark indices started off the week on a strong note, rallying for third consecutive session following sharp slide in crude oil prices and recovery in rupee.
BHRYY 532617 HCTHY TCHQY 532978 532755 532215 AXISBANK 534816 532281 HDFCBANK BJJQY INFRATEL 500034 INDIGO AXB IBN JETAIRWAYS 539207 TECHM 539448 AXBKY AXBA ICICIBANK BAJAJFINSV BAJFINANCE HDB 532174 500180 HCLTECH MANPASAND
Bulls retained charge at Dalal Street for the second consecutive session on Friday as the Sensex gained more than 300 points intraday. The rally was driven by banking & financials, auto, metals, oil and pharma stocks.
PAGEIND 590003 BHUSANSTL TCHQY 532755 CADILAHC 535789 532321 GSCLCEMENT 534816 BJJQY 500570 EICHERMOT CLNDY 500055 PGDQY 532827 YYBKY 518029 TECHM BAJAJFINSV BAJFINANCE TATASTEEL TATLY 500180 KOTAKBANK COALINDIA BHRYY IDBI 532978 533278 505200 500470 INFRATEL HDFCBANK TATAMOTORS 500034 YESBANK ECQRY 500116 KMBKY IBN IDKQY 532648 CDLYY IBULHSGFIN ICICIBANK TTST HDB 532174 500247 KARURVYSYA TTM
Market Update: The market held on to morning gains, with the Sensex rising around 150 points while the Nifty Midcap index extended rally, rising nearly 1.5 percent.
519588 PWQFY PANAMAPET 500325 BHUSANSTL UBL 532439 TCHQY ASIANPAINT 532321 PIDILITIND PDLTY 500850 BJJQY MS 500570 524820 500055 500331 JMFINANCIL SNDMY RLNIY GE 534690 515030 532827 UNITDSPR 531978 JETAIRWAYS 532945 YYBKY 530005 532432 BAJAJFINSV VED 500180 COALINDIA GOLDINFRA 500820 GOODYEAR IDBI PNCINFRA 514034 532899 532810 TTNQY 533477 532540 ZUARIGLOB 512529 RIGD INFRATEL INDHOTEL TATAMOTORS 500034 514043 SUNDARMFIN INDUSINDBK UBHOLDINGS 513599 532527 532648 UNBWY VTUWY CDLYY OBEROIRLTY HDB 500168 GNE KARURVYSYA EXCELINDUS TTM 523405 RICOAUTO 539150 PAGEIND 590003 HIMATSEIDE MS.PRE RKFORGE MS.PRF MS.PRG MS.PRA 532755 532478 532511 CADILAHC 532482 534816 JBFIND KSCL 500378 500252 CLNDY 500650 PGDQY ENKEIWHEL 520008 AMBIKCO 539302 LAXMIMACH TECHM BAJFINANCE MS.PRI TATASTEEL TATLY MS.PRK JINDALSAW UQNTY TCS 534809 PCJEWELLER 507458 500780 WABAG HINDCOPPER SHRIRAMEPC BHRYY MONTECARLO RELIANCE ASAHIINDIA 532617 533273 532978 533278 538836 GRANULES 500470 532187 HDFCBANK SEQUENT INDIACEM 590071 YESBANK GEC 500116 533269 POWERMECH PFC DFM OBZIY TTST LAKSHVILAS EXCELCROP
Bulls managed to get charge at Dalal Street on Tuesday as benchmark indices ended in the green for the first time in last six consecutive sessions, backed by short covering in most beaten down stocks. Investors closely watch corporate earnings, and the movement in crude oil prices and rupee.
BAJAJ-AUTO BHRYY 500325 RELIANCE 532538 532978 532977 505200 532187 534816 RIGD UCLQY BJJQY INFRATEL 500570 500493 TATAMOTORS EICHERMOT BHARATFORG RLNIY 500034 SBAZ ECQRY HINDALCO INDUSINDBK KMBKY UCLQF ULTRACEMCO HNDNF BAJAJFINSV BAJFINANCE KOTAKBANK 500247 500440 TTM
Order Win: Steel Strips Wheels has bagged another exports order from US Truck & Trailer aftermarket for its new truck steel wheels plant in Chennai.
BAJAJ-AUTO BALAJITELE TRITURBINE 507717 DABUR 532515 532712 DBRQY JUSTDIAL DHANUKA 500096 RCOM 532483 534816 SONATSOFTW 523574 500493 CLNDY BHARATFORG GLENMARK DPL MINDAIND JETAIRWAYS CNRYY 536507 APLAPOLLO BATAINDIA 533758 FRLDVR GLOBUSSPR CANBK COALINDIA SSWL ANDHRABANK 513262 BHRYY 532617 532539 532418 530239 532977 BHRQY 533278 GLKQY SUVEN 532221 535648 TVSSRICHAK 532382 509243 INFRATEL BHARTIARTL 523736 570002 HINDALCO TVTODAY FRL 533104 FLFL 533655 532454 HNDNF 532296 500043 JSTQY 500440
Buzzing Stocks: Dabur India lost a little over 1.5 percent in the morning trade on Tuesday after agencies reported seizure of assets worth Rs 21 crore from Pradip Burman, Director of the firm.
BAJAJ-AUTO BALAJITELE TRITURBINE 507717 DABUR 532515 DBRQY JUSTDIAL DHANUKA 500096 532483 534816 SONATSOFTW 523574 500493 CLNDY BHARATFORG SBAZ GLENMARK DPL MINDAIND JETAIRWAYS CNRYY APLAPOLLO BATAINDIA 533758 FRLDVR GLOBUSSPR CANBK COALINDIA ANDHRABANK BHRYY 532617 532539 532418 532977 BHRQY 533278 GLKQY 532221 535648 TVSSRICHAK 532382 509243 INFRATEL BHARTIARTL 523736 570002 HINDALCO TVTODAY FRL 533104 533655 532454 HNDNF 532296 500043 JSTQY 500440
Earnings Reaction: Share price of Dhunseri Petrochem locked at 10 percent lower circuit on the back of poor March quarter numbers.
BAJAJ-AUTO BALAJITELE TRITURBINE 507717 532515 JUSTDIAL DHANUKA 532483 534816 SONATSOFTW 523574 500493 CLNDY BHARATFORG SBAZ GLENMARK DPL MINDAIND JETAIRWAYS CNRYY APLAPOLLO BATAINDIA 533758 FRLDVR GLOBUSSPR CANBK COALINDIA ANDHRABANK BHRYY 532617 532539 532418 532977 BHRQY 533278 GLKQY 532221 535648 TVSSRICHAK 532382 509243 INFRATEL BHARTIARTL 523736 570002 HINDALCO TVTODAY FRL 533104 533655 532454 HNDNF 532296 500043 JSTQY 500440
2018-06-11 - Asif
Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...
2018-06-11 - Asif
Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...
2018-06-11 - Asif
Overview Stemline Therapeutics was incorporated under the laws of the State of Delaware in August 2003. Stemline Therapeutics is a clinical stage biopharmaceutical company focused on discovering, acquiring, developing and potentially commercializing innovative oncology therapeutics that target difficult to treat cancers. The company's clinical pipeline includes: SL-401, SL-801, and SL-701. SL-401 pivotal data; plans for registration and potential commercialization: SL-401 has completed a pivotal trial in patients with blastic plasmacytoid dendritic cell neoplasm, or BPDCN, and has successfully met the primary endpoint of the trial. SL-401 is a targeted therapy directed to the interleukin-3 receptor-a, or CD123. SL-401 was granted breakthrough therapy designation, or BTD, by the U.S. Food and Drug Administration, or FDA, for the treatment of patients with BPDCN. Based on the trial results and other data, the company expect to complete submission of a rolling Biologics License...
as of ET